The approval of Moderna's Spikevax for kids at higher risk of contracting the disease continues the company's regulatory ...

Dr. Marty Makary, FDA commissioner, joins 'Squawk Box' to discuss what hindsight tells science about the best route to take post-Covid, changes to the Vaccine Advisory Committee and much more.

The US Food and Drug Administration (FDA) has approved US mRNA specialist Moderna supplemental Biologics License Application ...

Ursula von der Leyen, the EU’s most powerful official, coasted to victory after a no-confidence vote on Thursday. Some of her ...

A new COVID-19 strain called Stratus may evade vaccine immunity, experts warn. With rising cases in the UK and unusual ...

A study by AIIMS Delhi revealed that nearly 40% of long Covid sufferers experience persistent fatigue, and 25% report ...

When the COVID-19 pandemic struck, the state's Department of Public Health faced unprecedented challenges in vaccine ...

Carlene Pavlos, executive director of the Massachusetts Public Health Association, one of the plaintiffs, said in a statement ...

Bangladesh is finally experiencing some relief. The virus has slowed down, with no new deaths or hospitalizations reported in ...

The Food and Drug Administration Thursday granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 ...

The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.